Fingerprint
Dive into the research topics of 'Pembrolizumab for the treatment of programmed death–ligand 1‒positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically